Exhibit 10.1
** **
REGULATION S SUBSCRIPTION AGREEMENT
FDCTech, Inc.
Shares of Common Stock for $25,000,000 at $2.00 per Share, subject to Section 2.2
** **
THE SECURITIES TO WHICH THIS AGREEMENT RELATES HAVE NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES, AND ARE BEING OFFERED AND SOLD ONLY TO NON-U.S. PERSONS IN OFFSHORE TRANSACTIONS IN RELIANCE ON REGULATION S UNDER THE SECURITIES ACT. THE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED IN THE UNITED STATES OR TO, OR FOR THE ACCOUNT OR BENEFIT OF, U.S. PERSONS EXCEPT IN ACCORDANCE WITH REGULATION S, PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION.
This Regulation S Subscription Agreement (this “Agreement”) is entered into as of 13 November 2026 (the “Signing Date”) between FDCTech, Inc., a Delaware corporation with its principal office at Ground Floor, 10A Eleftheriou Venizelou Street, 3035 Limassol, Cyprus (the “Company”), and Quant Analytic Technologies Inc., a company organized under the laws of St. Kitts and Nevis with its principal office at Southpac Trust Nevis limited, Hunkins Plaza, Main Street, Charlestown, Nevis (the “Investor”).
The Investor wishes to subscribe for, and the Company wishes to issue, shares of the Company’s common stock for an aggregate of $25,000,000 payable in instalments, each priced when paid at $2.00 per share or, if lower, the market price, but not less than $1.25 per share, in an offshore transaction in reliance on Regulation S, on the terms of this Agreement. The parties therefore agree as follows.
1. Definitions
1.1 In this Agreement:
“Affiliate” has the meaning given in Rule 405 under the Securities Act.
“Beneficially Own” has the meaning given by Rule 13d-3 under the Exchange Act, and “Beneficially Owns” and “Beneficial Ownership” have corresponding meanings. The Investor’s beneficial ownership includes that of its Affiliates and of any person with whom it would form a “group” under Section 13(d)(3) of the Exchange Act.
“Business Day” means a day other than a Saturday, Sunday or day on which banks in New York, New York are authorized or required to close.
“Commission” means the U.S. Securities and Exchange Commission. “Commitment” means $25,000,000.
“Common Stock” means the Company’s common stock, par value $0.0001 per share. “Company Default” has the meaning given in Section 8.1.
“Disclosure Statement” means the Investor Disclosure Statement dated 13 November 2026 delivered by the Company to the Investor.
“Escrow Agent” means [Escrow Agent TBD] and “Escrow Agreement” means the escrow agreement among the Company, the Investor and the Escrow Agent reflecting Schedule B.
“Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended.
“Excluded Issue” means an issue of Common Stock (a) on conversion or exercise of a security outstanding and disclosed at the Signing Date, (b) under an employee equity plan approved by the board, up to 10% of the Common Stock outstanding at the Signing Date, (c) pro rata to all holders of Common Stock, or (d) of the Shares.
“Full Payment” means receipt by the Company of Paid Amounts equal to the Commitment.
| Page 1 |
“Instalment” means each payment set out in Schedule A, and “Payment Date” means the date on which it is due.
“Investor Default” has the meaning given in Section 7.1.
“Independent Director” means an individual who (a) is “independent” under the listing rules of the Principal Market, or, if the Common Stock is not then listed on a national securities exchange, under the independence standards of Nasdaq Listing Rule 5605(a)(2) as applied by the board in good faith, and the independence requirements of Rule 10A-3 under the Exchange Act for audit committee service; (b) is not, and in the preceding three years has not been, an officer, employee, consultant, agent or designee of the Investor or any of its Affiliates or any person with whom the Investor forms a “group”; (c) does not receive, and has not received, any compensation, fee or other payment from the Investor or its Affiliates, other than as a director of the Company; (d) has no material business, financial, family or other relationship with the Investor or its Affiliates that, in the board’s reasonable judgment, would interfere with the exercise of independent judgment as a director of the Company; and (e) is not a director, officer, employee or equity holder of a competitor of the Company or its subsidiaries, other than holdings of less than 1% of a class of publicly traded securities.
“Paid Amount” means the aggregate amount received by the Company in cleared funds under this Agreement. “Principal Market” means the OTCID Basic Market operated by OTC Markets Group Inc. or, if the Common Stock is then quoted on another tier of OTC Markets or listed on a national securities exchange, that tier or exchange.
“Purchase Price” means the price per Share for each Instalment set under Section 2.2, adjusted only under Section 2.3.
“Regulation S” means Regulation S under the Securities Act.
“SEC Reports” means the reports, schedules, registration statements and other documents filed by the Company with the Commission under the Securities Act or the Exchange Act, as amended or supplemented.
“Shares” means the shares of Common Stock subscribed for under this Agreement, adjusted only under Section 2.3. Their number depends on the Purchase Price of each Instalment under Section 2.2: 12,500,000 if every Instalment is priced at $2.00, more if any Instalment is priced lower, and no more than 20,000,000 (if every Instalment is priced at the $1.25 floor).
“Unfunded Commitment” means, at any time, the Commitment less the Paid Amount.
1.2 References to a rule or regulation are to it as amended from time to time. “Including” means including without limitation. Headings do not affect interpretation.
2. Subscription
2.1 Commitment. The Investor irrevocably subscribes for the Shares at the Purchase Price and agrees to pay the Commitment in the Instalments, on the Payment Dates, set out in Schedule A. The Investor’s obligation to pay each Instalment is unconditional, except that it is suspended while a Company Default is continuing under Section 8.2. Each Instalment must be paid in full in U.S. dollars, in immediately available funds, to the account the Company designates in writing, without set-off, counterclaim or deduction.
2.2 Purchase Price. Each Instalment is priced when it is paid. Its Purchase Price is $2.00 per Share, or, if lower, the closing price of the Common Stock on the Principal Market on the last trading day before payment, but never less than $1.25 per Share. If no shares traded on that day, the most recent earlier closing price is used. An Instalment paid early or late is priced as if it had been paid on its Payment Date. Each Instalment buys a number of Shares equal to the Instalment divided by its Purchase Price, rounded down to the nearest whole Share. That number is fixed when the Instalment is priced, including for Escrow Shares issued later. Within two Business Days after each Instalment is paid, the Company will confirm in writing to the Investor and the Escrow Agent its Purchase Price and the number of Shares bought.
2.3 Adjustments. If the Company effects a stock split, reverse stock split, stock dividend, combination or reclassification of the Common Stock, the number and Purchase Price of Shares not yet issued, and the other prices and share numbers in this Agreement, are proportionately adjusted so that the Commitment and the Investor’s proportionate entitlement are unchanged. A closing price from before the event that is used to price a later Instalment is adjusted in the same way. Apart from Section 2.2 and this Section, no adjustment is made for any later issuance of securities by the Company or for any other reason.
| Page 2 |
2.4 Prepayment. The Investor may prepay all or any part of the Unfunded Commitment at any time. A prepayment is applied to the next Instalments due. Despite Sections 2.2 and 2.6, each Instalment, or part of one, that is prepaid is priced as if it had been paid on its Payment Date, and the Company will confirm its Purchase Price and the number of Shares it bought within two Business Days after that date. Those Shares are issued within three Business Days after that Payment Date or, if they are Escrow Shares, released under Section 2.7, but not before that Payment Date.
2.5 Reserved Shares and share escrow. The Company’s board of directors has authorized the issuance of the Shares and has reserved 20,000,000 authorized but unissued shares of Common Stock for that purpose. On the Signing Date, the Company will deliver to the Escrow Agent irrevocable instructions to its transfer agent in the form of Exhibit D in respect of up to 6,400,000 Escrow Shares (the “Share Instructions”), to be released by the Escrow Agent only as provided in this Agreement and the Escrow Agreement. The Shares are not issued, and the Investor has no rights as a stockholder in respect of them, until they are issued under Section 2.6, 7.2 or 8.3.
2.6 Issuance of Shares. Subject to Sections 7.2 and 8.3, the Shares will be issued as follows: (a) the Shares bought by the first two Instalments ($8,000,000 in aggregate, and not more than 6,400,000 Shares) (the “Escrow Shares”) will not be issued until Full Payment; pending Full Payment the Escrow Shares remain authorized but unissued, and the Share Instructions in respect of them are held by the Escrow Agent and released only as provided in Section 2.7 and the Escrow Agreement; and (b) in respect of each Instalment after the first two, within three Business Days after the later of the date the Company receives that Instalment in cleared funds and its Payment Date, the Company will cause its transfer agent to issue to the Investor, in book-entry form and bearing the legends in Section 6.1, the Shares bought by that Instalment under Section 2.2. The Company will maintain a ledger of all Paid Amounts, their Purchase Prices, and all Shares issued under this Agreement, reconciled with its transfer agent, and will provide a copy to the Investor on request. No Share will be issued more than once in respect of the same Paid Amount.
2.7 Release of Escrow Shares. Within three Business Days after Full Payment, the Escrow Agent will release the Share Instructions to the Company’s transfer agent and the Company will cause its transfer agent to issue to the Investor the Escrow Shares, less any Escrow Shares previously issued to the Investor under Section 7.2 or 8.3, in book-entry form, bearing the legends in Section 6.1.
2.8 Late payment. Any Instalment not paid within 5 Business Days of the relevant Payment Date bears interest at 4% per year from the sixth Business Day following the relevant Payment Date until paid. Interest is payable in cash and does not increase the number of Shares.
2.9 Use of Instalments. The Company may use each Instalment on receipt, in its sole discretion. Paid Amounts are not refundable except as stated in Section 8.4.
3. [Reserved]
4. Representations and Warranties of the Company
** **
The Company represents and warrants to the Investor, as of the Signing Date and each Payment Date:
4.1 Organization and authority. The Company is duly incorporated and in good standing under the laws of Delaware and has full corporate power and authority to enter into and perform this Agreement and to issue the Shares. The execution and delivery of this Agreement by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary corporate action and no further consent or authorization of the Company or its board of directors is required. This Agreement has been duly executed and delivered by the Company and is a valid and binding obligation of the Company, enforceable in accordance with its terms, subject to bankruptcy, insolvency and similar laws and general principles of equity.
4.2 Valid issuance and share capital. The sale and issuance of the Shares, in accordance with the terms and on the bases of the representations and warranties of the Investor set forth herein, may and shall be properly issued by the Company to the Investor pursuant to Regulation S and any applicable U.S. state law. The Shares have been duly authorized and reserved. When issued and paid for under this Agreement, they will be validly issued, fully paid and non-assessable, and free of liens created by the Company, other than restrictions on transfer under this Agreement and applicable securities laws. Neither the sales of the Shares pursuant to, nor the Company’s performance of its obligations under, this Agreement shall (a) result in the creation or imposition of any liens, charges, claims or other encumbrances upon the Shares or any of the assets of the Company, or (b) entitle the other holders of the Common Stock of the Company to preemptive or other rights to subscribe to or acquire the Common Stock or other securities of the Company. The Shares shall not subject the Investor to personal liability by reason of the ownership thereof.
| Page 3 |
Schedule C sets out full and complete details of the authorized share capital of the Company, together with any outstanding options, warrants, rights (including conversion or pre-emption rights and rights of first refusal or similar rights) to purchase or acquire from the Company any shares of common stock or preferred stock. Except as set out in Schedule C or as provided in this Agreement, there are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any shares of common stock or preferred stock, or any securities convertible into or exchangeable for shares of common stock or preferred stock.
4.3 No conflict. The execution and performance of this Agreement do not and will not (i) violate the Company’s certificate of incorporation or bylaws, or any law or order applicable to the Company, or (ii) result in a material breach or default (or an event that with notice or lapse of time or both would become a material breach or default) of or under any material agreement to which the Company is a party, or give to others any rights of termination, amendment, acceleration or cancellation of, any material agreement to which the Company is a party, or (iii) result in a violation of any federal, state, local or foreign law, rule, regulation, order, judgment or decree (including federal and state securities laws and regulations) applicable to the Company or by which any property or asset of the Company is bound or affected (except for such conflicts, defaults, terminations, amendments, accelerations, cancellations and violations as would not, individually or in the aggregate, have a material adverse effect on the business, operations, properties, prospects or condition (financial or otherwise) of the Company) nor is the Company otherwise in violation of, conflict with or in default under any of the foregoing. The Company is not required under U.S. federal, state or local law, rule or regulation to obtain any consent, authorization or order of, or make any filing or registration with, any court or governmental agency in order for it to execute, deliver or perform any of its obligations under this Agreement or issue and sell the Common Stock in accordance with the terms hereof (other than any SEC, FINRA, or state securities filings that may be required to be made by the Company in connection with the matters contemplated by this Agreement).
4.4 SEC Reports. To the best of Company’s knowledge, the Company has not provided to the Investor any information that, according to applicable law, rule or regulation, should have been disclosed publicly prior to the date hereof by the Company, but which has not been so disclosed. The SEC Reports filed since January 1, 2025, as of their respective filing dates (or, if amended or superseded, as of the date of the amending or superseding filing), complied in all material respects with the applicable requirements of the Securities Act and the Exchange Act. Except as disclosed in the Disclosure Statement, they did not, when so filed, contain an untrue statement of a material fact or omit a material fact required to be stated in them or necessary to make the statements in them, in light of the circumstances in which they were made, not misleading. The financial statements of the Company included in the SEC Reports comply as to form and substance in all material respects with applicable accounting requirements and the published rules and regulations of the SEC, or other applicable rules and regulations with respect thereto. Such financial statements have been prepared in accordance with generally accepted accounting principles applied on a consistent basis during the periods involved (except (a) as may be otherwise indicated in such financial statements or the notes thereto or (b) in the case of unaudited interim statements, to the extent they may not include footnotes or may be condensed or summary statements) and fairly present in all material respects the financial position of the Company as of the dates thereof and the results of operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments).
4.5 Regulation S. Neither the Company, nor any of its Affiliates, nor any person acting on its or their behalf, has engaged in any directed selling efforts (as defined in Regulation S) with respect to the Shares, and the Company is offering the Shares only in an offshore transaction in reliance on Regulation S.
4.6 No other representations. Except as expressly stated in this Section 4 and Section 6.7, the Company makes no representation or warranty, express or implied, and the Investor acknowledges that it has not relied on any other representation or warranty.
5. Representations, Warranties and Acknowledgments of the Investor
The Investor represents, warrants and acknowledges to the Company, as of the Signing Date and each Payment Date:
5.1 Capacity and authority. The Investor has full legal capacity, power and authority to enter into and perform this Agreement, which is a valid and binding obligation of the Investor, enforceable in accordance with its terms. If the Investor is an entity, it is duly organized and in good standing under the laws of its jurisdiction of organization.
| Page 4 |
5.2 Financial capacity. The Investor has, and will have on each Payment Date, sufficient immediately available funds to pay the Commitment when due.
5.3 Non-U.S. person. The Investor is not a “U.S. person” as defined in Rule 902(k) of Regulation S and is not acquiring the Shares for the account or benefit of any U.S. person. If the Investor is an entity, it was not formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act.
5.4 Offshore transaction. The offer of the Shares was made to the Investor outside the United States, and the Investor was outside the United States when it received the offer and when it executed this Agreement.
5.5 No directed selling efforts. The Investor has not engaged in, and will not engage in, any directed selling efforts in the United States with respect to the Shares, and is not a distributor or dealer within the meaning of Regulation S.
5.6 Restricted securities. The Investor understands that: (a) the Shares have not been registered under the Securities Act or any state securities law; (b) the Shares are “restricted securities” within the meaning of Rule 144 under the Securities Act and Rule 905 of Regulation S; and (c) the Shares may be resold only in accordance with Regulation S, pursuant to an effective registration statement, or pursuant to an available exemption from registration, including Rule 144 if and when available. The Company has no obligation to register the Shares or to make any exemption available.
5.7 Resale and hedging. The Investor will offer, sell or otherwise transfer the Shares only in accordance with Regulation S, pursuant to an effective registration statement, or pursuant to an available exemption from registration. It will not engage in hedging transactions involving the Shares unless in compliance with the Securities Act.
5.8 Investment intent. The Investor is acquiring the Shares for its own account, for investment and not with a view to any distribution in violation of the Securities Act.
5.9 Sophistication and information. The Investor has such knowledge and experience in financial and business matters that it can evaluate the merits and risks of an investment in the Shares, and can bear the economic risk of losing its entire investment. The Investor has received and reviewed the Disclosure Statement and has had access to the SEC Reports. It has had the opportunity to ask questions of, and receive answers from, the Company, and to obtain any additional information it considers necessary.
5.10 No other reliance. In deciding to invest, the Investor has relied only on the Disclosure Statement, the SEC Reports, the Company’s representations in Section 4, and its own independent investigation and advice. It has not relied on any other statement, projection or information, whether oral or written, from the Company or any person acting on its behalf.
5.11 Use of proceeds. The Company has made no representation, warranty, covenant or commitment regarding the use of the Paid Amounts.
5.12 Risks. The Investor understands that an investment in the Shares is speculative and involves a high degree of risk, including the risks described in the Disclosure Statement and the SEC Reports. In particular, the Purchase Price is never less than $1.25 per Share and may exceed the market price of the Common Stock when an Instalment is paid or when the Shares are issued, and Paid Amounts are not refundable except as stated in Section 8.4.
5.13 Tax and legal advice. The Investor has relied solely on its own legal, tax and financial advisers, including on the tax consequences of acquiring, holding and disposing of the Shares in its jurisdiction and the United States.
5.14 Source of funds; sanctions; anti-money laundering. The funds used to pay the Commitment are derived from legitimate sources and are not the proceeds of any unlawful activity. Neither the Investor, nor any of its beneficial owners, directors or officers, is a person subject to sanctions administered by the United States (including OFAC), the United Nations, the European Union or the United Kingdom, or located in a comprehensively sanctioned jurisdiction. The Investor will promptly provide any information the Company reasonably requests to comply with applicable anti-money laundering, know-your-customer and sanctions laws. The Investor’s ultimate beneficial owner(s) are as stated in Exhibit B.
5.15 Local law. The Investor’s subscription complies with the laws of its jurisdiction of residence or organization. No consent or filing in that jurisdiction is required of the Company in connection with the issuance of the Shares.
5.16 No brokers. No broker, finder or placement agent is entitled to a fee from the Company based on arrangements made by the Investor.
| Page 5 |
5.17 Reporting obligations. The Investor is solely responsible for compliance with any obligations it has under Sections 13(d), 13(g) and 16 of the Exchange Act and the rules under them.
6. Covenants
6.1 Legends. The Shares will bear a legend substantially as follows, together with any legend required by applicable state law or the Company’s transfer agent, and the Company will place stop-transfer instructions with its transfer agent:
“THE SECURITIES REPRESENTED HEREBY HAVE BEEN OFFERED AND SOLD TO NON-U.S. PERSONS IN AN OFFSHORE TRANSACTION IN RELIANCE ON REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OR ANY STATE SECURITIES LAWS. THEY ARE “RESTRICTED SECURITIES” AND MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED IN THE UNITED STATES OR TO, OR FOR THE ACCOUNT OR BENEFIT OF, U.S. PERSONS EXCEPT IN ACCORDANCE WITH REGULATION S, PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION. HEDGING TRANSACTIONS INVOLVING THESE SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE SECURITIES ACT.”
6.2 Transfers. The Company will refuse to register any transfer of Shares not made in accordance with Regulation S, pursuant to an effective registration statement, or pursuant to an available exemption from registration. The Investor may not assign or transfer its rights to receive the Shares before they are issued.
6.3 Legend removal. When the Shares become eligible for resale without restriction under Rule 144 or Regulation S, the Company will, on the Investor’s written request and delivery of customary representation letters, use commercially reasonable efforts to cause its transfer agent to remove the legend. The Company bears the cost of any opinion of its counsel the transfer agent requires.
6.4 Disclosure. The Company may disclose the existence and terms of this Agreement, the identity of the Investor, and all payments and defaults under this Agreement, in its SEC Reports, press releases and other communications as the Company determines is required by law or the rules of the Principal Market. It may also file this Agreement as an exhibit to its SEC Reports.
6.5 Confidentiality and trading. The Investor will keep confidential any material non-public information about the Company it receives, other than through public disclosure. It will comply with applicable securities laws in trading Common Stock. If the Investor or its designee is a director or board observer of the Company, it will also comply with the Company’s insider trading policy.
6.6 Reservation of shares. Until the Shares are issued or this Agreement terminates, the Company will keep reserved at least 20,000,000 authorized but unissued shares of Common Stock, less any Shares already issued.
7. Investor Default
7.1 Events. Each of the following is an “Investor Default”:
| (a) | the Investor fails to pay any Instalment, or interest under Section 2.8, within ten Business Days after its Payment Date; |
| (b) | the Investor becomes subject to bankruptcy, insolvency, liquidation or similar proceedings, or is unable to pay its debts as they fall due; or |
| (c) | any representation in Section 5.3 to 5.8 or 5.14 is untrue when made or repeated. |
7.2 Remedies. While an Investor Default is continuing, the Company may elect by written notice either:
| (a) | Termination with liquidated damages: to terminate the Investor’s right and obligation to pay the Unfunded Commitment. In that case, the Company retains the Paid Amount and, within five Business Days, issues to the Investor the Shares bought by the Paid Amount under Section 2.2, reduced by the percentage of the Paid Amount that the Liquidated Damages represent and rounded down to the nearest whole Share, less the number of Shares previously issued to the Investor under Section 2.6(b); if that calculation produces a negative number, no further Shares are issued, and the Company may recover the shortfall in Liquidated Damages from the Investor as a debt. “Liquidated Damages” means 7.0% of the Unfunded Commitment at the date of the notice; or |
| Page 6 |
| (b) | Enforcement: to require payment of each overdue Instalment, and of each later Instalment as it falls due, by specific performance, and to recover its damages. Shares bought by amounts recovered under this paragraph are issued under Sections 2.6 and 2.7. While an Investor Default is continuing, the Company may at any time, by further written notice, elect to proceed under paragraph (a) instead, in which case any amount recovered under this paragraph (b) is treated as part of the Paid Amount and the Shares attributable to it are issued under paragraph (a). The Company may not recover the same loss more than once under this Section 7, or under paragraph (a) if the Company later makes that election. |
7.3 Nature of Liquidated Damages. The parties agree that the Company’s losses from an Investor Default would be difficult to determine, including the costs of commitments made and opportunities forgone in reliance on the Commitment. They agree that the Liquidated Damages are a reasonable estimate of those losses and not a penalty. If the Company elects under Section 7.2(a), the Liquidated Damages are its sole monetary remedy for the Investor’s failure to pay the Unfunded Commitment.
7.4 No refund. The Investor has no right to repayment of any Paid Amount following an Investor Default. On termination under Section 7.2(a), the Investor’s rights under Section 9 terminate, other than rights based on Shares actually issued.
7.5 Other rights. The Company’s rights under this Section 7 are in addition to its rights under any other agreement between the Company and the Investor or its Affiliates.
8. Company Default
8.1 Events. Each of the following is a “Company Default”:
| (a) | the Company fails to issue Shares when required by this Agreement, and does not remedy the failure within 10 Business Days after written notice; |
| (b) | the Company becomes subject to bankruptcy, insolvency, liquidation or similar proceedings; or |
| (C) | any representation in Section 4 is untrue in any material respect when made and, if capable of remedy, is not remedied within 30 days after written notice. |
8.2 Suspension. While a Company Default is continuing, the Investor’s obligation to pay Instalments is suspended and no Investor Default arises from non-payment. If the Company Default is remedied, the suspended Instalments are due within five Business Days and the remaining Payment Dates are extended by the length of the suspension.
8.3 Remedies. If a Company Default continues for 30 days (or immediately, for a Company Default under Section 8.1(b) or (c)), the Investor may, by written notice:
| (a) | terminate its obligation to pay the Unfunded Commitment, without liability; |
| (b) | require the Company to issue, within five Business Days, the Shares bought by the Paid Amount under Section 2.2, less the number of Shares previously issued to the Investor under Section 2.6(b), with no other deduction; and |
| (c) | recover its actual damages. |
8.4 Cash repayment. If the Company is legally unable to issue Shares for a Paid Amount under Section 8.3(b), it must repay that Paid Amount in cash within fifteen (15) Business Days. The Company has no other obligation to repay Paid Amounts in cash, and the repayment obligation is an unsecured obligation of the Company.
9. Investor Rights
9.1 Director nomination. While the Investor Beneficially Owns at least 5% of the outstanding Common Stock, determined on each Payment Date after giving effect to the payment then made and counting only Shares that have been paid for in full (including Shares held in the share escrow under Section 2.5) against the shares of Common Stock then outstanding, the Investor may nominate one individual for appointment or election to the Company’s board of directors (the “Investor Director”). The nominee must:
| (a) | be qualified to serve as Independent Director under applicable law, the rules of the Principal Market and the Company’s governance policies; |
| Page 7 |
| (b) | complete the Company’s customary director questionnaire and background check; and |
| (c) | be reasonably acceptable to the board’s nominating committee or, if there is none, the board. |
The Company will appoint the Investor Director within 30 days after the nomination satisfies these conditions and will include the Investor Director in its slate of nominees while this right continues. The Investor Director is entitled to the same indemnification, D&O insurance coverage and expense reimbursement as the Company’s other non-employee directors.
9.3 Termination of rights. The rights in this Section 9 are personal to the Investor and are not transferable, other than to an Affiliate that agrees to be bound by this Agreement. Each right terminates automatically when the Investor’s Beneficial Ownership falls below the relevant threshold. The Investor will then cause the Investor Director to tender his or her resignation, which the board may accept or decline. Nothing in this Section 9 limits the board’s fiduciary duties or the Company’s obligations under applicable law or Principal Market rules.
9.4 Participation in Private Fund Raising. This Section applies until the second anniversary of the Signing Date and only while the Investor and its Affiliates together hold at least 4,000,000 shares of Common Stock that have been paid for in full (adjusted under Section 2.3, counting Escrow Shares). If the Company proposes to issue for cash any shares of Common Stock, or any securities convertible into or exercisable for Common Stock, other than in a public offering registered under the Securities Act or an Excluded Issue, it shall give the Investor written notice of the number of securities, the price and the other material terms at least five Business Days before the issue. Within five Business Days after that notice, the Investor (or an Affiliate it nominates) may elect to subscribe, at the same price and on the same terms, for up to the number of those securities needed to keep the Investor’s percentage of the Common Stock, on a fully diluted basis and counting Shares it has paid for in full or is committed to acquire under this Agreement, at its level immediately before the issue. The Company shall issue those securities to the Investor at the same time as the other securities are issued, against payment of the price. If the Company issues the securities at a lower price or on terms more favorable to the subscribers than those notified, or issues them without giving notice under this Section, the Investor may subscribe for its entitlement at that price and on those terms by written notice within fifteen Business Days after the Company publicly announces or notifies the Investor of the issue, and in any event within sixty days after the issue. Any subscription under this Section is subject to Section 5, applicable securities laws and any approval of the Principal Market, and the Investor will deliver an updated Exhibit B before the securities are issued. The Investor will keep each notice under this Section confidential until the issue is publicly announced.
10. Term
10.1 This Agreement continues until the Shares (or any lesser number determined under Section 7.2(a) or 8.3) have been issued and all amounts due under it have been paid. Termination does not affect any liability for prior breach.
10.2 Sections 5, 6, 7.3, 7.4, 8.4, 9 (for as long as the relevant ownership threshold is met) and 11 survive. The representations in Sections 4 and 5 survive for 12 months after the last Shares are issued, except Sections 5.3 to 5.8 and 5.14, which survive indefinitely.
11. General
11.1 Indemnification. Each party will indemnify the other and its directors, officers and Affiliates against losses arising from any breach of its representations, warranties or covenants in this Agreement. Neither party is liable for consequential, special or punitive damages. Except in the case of fraud, each party’s aggregate liability under this Section is limited to the Commitment. This Section does not limit Sections 7, 8, and 9.
11.2 Governing law. This Agreement is governed by the laws of the State of Delaware, without regard to its conflict of laws principles.
11.3 Arbitration. Any dispute arising out of or in connection with this Agreement will be finally resolved by arbitration under the ICC Rules of Arbitration by one arbitrator. The seat of arbitration is New York, and the language is English. Judgment on the award may be entered in any court of competent jurisdiction. Nothing in this Section prevents a party from seeking interim or injunctive relief from any competent court.
11.4 Notices. Notices must be in writing and delivered by hand, international courier or email (with confirmation) to the addresses below each party’s signature, or another address a party designates by notice.
11.5 Expenses. Each party bears its own costs and expenses in connection with this Agreement, except as stated in Section 6.3.
| Page 8 |
11.6 Entire agreement. This Agreement, including its Schedules and Exhibits, and the Escrow Agreement together constitute the entire agreement between the parties with respect to its subject matter. It supersedes all prior understandings with respect to that subject matter.
11.7 Amendment and waiver. This Agreement may be amended only in writing signed by both parties. No waiver is effective unless in writing.
11.8 Assignment. The Investor may not assign this Agreement except to an Affiliate that is a non-U.S. person, that makes the representations in Section 5, and that agrees in writing to be bound by this Agreement. The Company may not assign this Agreement without the Investor’s consent, except to a successor by merger.
11.9 Third parties. Except under Section 11.1, no person other than the parties has any right to enforce this Agreement.
11.10 Severability. If any provision is held invalid, the remainder of this Agreement is unaffected.
11.11 Counterparts. This Agreement may be executed in counterparts and by electronic signature, each of which is an original and all of which together are one instrument.
[Signature page follows]
| Page 9 |
IN WITNESS WHEREOF, the parties have executed this Agreement as of the Signing Date.
| FDCTech, Inc. | ||
| By: | ||
| Name: | Mitchell M. Eaglstein | |
| Title: | Chief Executive Officer and Director | |
| Address: | Ground Floor, 10A Eleftheriou Venizelou Street, 3035 Limassol, Cyprus | |
| Email: | mitch@fdctech.com | |
| INVESTOR: Quant Analytic Technologies Inc. | ||
| By: | ||
| Name: | Oscar Hilt Tatum, IV | |
| Title | (if entity): Director | |
| Address: | Southpac Trust Nevis limited, Hunkins Plaza, Main Street, Charlestown, Nevis | |
| Email: | htatum@ipointcapital.com |
| Page 10 |
SCHEDULE A — PAYMENT SCHEDULE
| Instalment | Payment Date | Amount | ||
| 1 | 13 November 2026 | $4,000,000 | ||
| 2 | 13 December 2026 | $4,000,000 | ||
| 3 | 12 January 2027 | $2,000,000 | ||
| 4 | 11 February 2027 | $2,000,000 | ||
| 5 | 13 March 2027 | $2,000,000 | ||
| 6 | 12 April 2027 | $2,000,000 | ||
| 7 | 12 May 2027 | $2,000,000 | ||
| 8 | 11 June 2027 | $2,000,000 | ||
| 9 | 11 July 2027 | $2,000,000 | ||
| 10 | 10 August 2027 | $2,000,000 | ||
| 11 | 9 September 2027 | $1,000,000 | ||
| Total | $25,000,000 (12,500,000 Shares at $2.00, or more if priced lower under Section 2.2) |
** **
If a Payment Date is not a Business Day, payment is due on the next Business Day.
| Page 11 |
SCHEDULE B — ESCROW TERMS
Part 1 — Key terms of the Escrow Agreement
1. Share Instructions. The Escrow Agent holds the Share Instructions (Exhibit D). It releases them to the Company’s transfer agent for onward transmission to the Investor only on: (a) Full Payment; (b) the Company’s certificate of an election under Section 7.2(a), stating the number of Shares to be issued; or (c) the Investor’s certificate of a termination under Section 8.3, stating the number of Shares to be issued. In cases (b) and (c), the Escrow Agent first gives the other party five Business Days’ notice, and disputes are referred to arbitration under Section 11.3 without delaying any undisputed issuance.
2. Fees and duties. The Escrow Agent’s fees are to be paid by the Company. Its duties are ministerial and limited to those set out in the Escrow Agreement.
3. Governing law. The Escrow Agreement is governed by the law of the Escrow Agent’s jurisdiction, with disputes between the Company and the Investor referred to arbitration under Section 11.3.
SCHEDULE C — CAPITALIZATION
Fully diluted capitalization table of the Company as of the Signing Date — figures below from the Company’s Form 10-Q for the quarter ended September 30, 2026 and transfer-agent records.
As of 13 November 2026 (to be updated to the Signing Date):
1. Authorized capital. 750,000,000 shares of Common Stock, par value $0.0001 per share, and 15,000,000 shares of preferred stock, par value $0.0001 per share (as increased by the Certificate of Amendment filed August 17, 2026), of which 10,000,000 shares are designated Series A Convertible Preferred Stock and 3,000,000 shares are designated Series B Convertible Preferred Stock.
2. Common Stock. 125,323,068 shares issued and outstanding as of September 24, 2026 (per the Company’s Form S-1/A filed on that date and its transfer agent, Colonial Stock Transfer), and as of September 30, 2026. One vote per share.
3. Series A Convertible Preferred Stock. 4,500,000 shares issued and outstanding. Under the Certificate of Designation as amended August 17, 2026, each share carries fifty (50) non-cumulative votes per share (not adjusted for the July 2026 reverse stock split), voting together with the Common Stock; all conversion and exchange rights have been eliminated, so the Series A is not convertible into Common Stock or any other class, and its rights consist solely of the voting rights and liquidation rights set out in the Certificate of Designation. Shares reacquired by the Company revert to undesignated preferred stock. On this basis, holders of the Series A Preferred Stock control approximately 64% of the total voting power of the Company’s capital stock.
4. Series B Convertible Preferred Stock. 3,000,000 shares designated; none outstanding. All 2,371,844 shares previously outstanding were converted into 118,592,200 shares of Common Stock on July 13, 2026 at 50 shares of Common Stock per share of Series B.
5. Promissory notes. The promissory note issued to Vanquish Funding Group Inc. on August 20, 2026 (principal $329,940) is not convertible absent an event of default; following an event of default, and from 180 days after issuance, the holder may convert the outstanding balance into Common Stock at 65% of the lowest trading price in the preceding ten trading days, subject to a 4.99% beneficial-ownership limitation, and the Company has reserved 1,147,118 shares of Common Stock with its transfer agent for that purpose.
7. Pre-emption and similar rights. None, other than the rights granted to the Investor under Section 9.4 of this Agreement.
8. Reserved shares. 20,000,000 shares of Common Stock reserved for issuance under this Agreement (Section 2.5).
| Page 12 |
EXHIBIT A – INTENTIONALLY LEFT BLANK
| Page 13 |
** **
EXHIBIT B — INVESTOR CERTIFICATE (REGULATION S AND KYC)
** **
The Investor certifies to the Company, as of the date below, that:
1. It is not a U.S. person (Rule 902(k)) and is not acquiring the Shares for the account or benefit of any U.S. person.
2. It is acquiring the Shares in an offshore transaction and was outside the United States when the offer was made and when this certificate was signed.
3. It agrees to resell the Shares only in accordance with Regulation S, pursuant to registration under the Securities Act, or pursuant to an available exemption from registration, and not to engage in hedging transactions involving the Shares unless in compliance with the Securities Act.
4. Investor details: Quant Analytic Technologies Inc. ; jurisdiction of residence or organization: St. Kitts and Nevis; registered address: Southpac Trust Nevis Limited, Hunkins Plaza, Main Street, Charlestown, Nevis; passport or registration number: C 50245; ultimate beneficial owner(s) and percentage ownership Oscar Hilt Tatum, IV, 100% ownership; source of funds for the Commitment shall be capital contributions and/or shareholder loans from the Investor’s sole shareholder and ultimate beneficial owner, Oscar Hilt Tatum, IV; digital wallet from which funds will be remitted: 0x3ecE9F8Ccf002154C28143eC17aEEf7a2A758446 .
5. The information above is true, complete and correct, and the Investor will promptly notify the Company of any change.
| Quant Analytic Technologies Inc. | ||
| By: | ||
| Name / Title: Oscar Hilt Tatum, IV / Director | ||
| Date: 13 November 2026 |
| Page 14 |
EXHIBIT C – INTENTIONALLY LEFT BLANK
| Page 15 |
** **
EXHIBIT D — FORM OF IRREVOCABLE INSTRUCTIONS TO TRANSFER AGENT
** **
To: Colonial Stock Transfer
Copy: [TBD] - the Escrow Agent
Re: FDCTech, Inc. — up to 6,400,000 shares of Common Stock reserved for Quant Analytic Technologies Inc.
1. FDCTech, Inc. (the “Company”) has reserved 6,400,000 authorized but unissued shares of its common stock for issuance to Quant Analytic Technologies Inc. under a Regulation S Subscription Agreement dated 13 November 2026.
2. The Company irrevocably instructs you, on receipt of these instructions from the Escrow Agent together with its certificate stating the number of shares to be issued (not exceeding 6,400,000, as adjusted for any stock split or similar event), to issue that number of shares in book-entry form in the name of Quant Analytic Technologies Inc. The shares are to bear the Regulation S restrictive legend set out in Section 6.1 of the Subscription Agreement (a copy of which is attached), and you are to note stop-transfer instructions against them.
3. These instructions may not be revoked or amended without the written consent of Quant Analytic Technologies Inc. and [Escrow Agent, TBD], except to reflect a stock split or similar adjustment.
4. Pending release, the reserved shares are not issued or outstanding.
5. Any costs associated with the Escrow Agent and the Transfer Agent to be borne by the Company.
| FDCTech, Inc. | ||
| By: | ||
| Name: | Mitchell M. Eaglstein | |
| Title: | Chief Executive Officer and Director |
** **